Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Social and economic burden of walking and mobility problems in multiple sclerosis.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
Early netrin-1 expression impairs central nervous system remyelination.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Selection and optimization of therapy for progressive type multiple sclerosis.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Therapeutic plasma exchange in neuromyelitis optica: A case series.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
Environmental factors and multiple sclerosis severity: a descriptive study.
[The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
A mechanism-based classification of pain in multiple sclerosis.
Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Pages
« first
‹ previous
…
328
329
330
331
332
333
334
335
336
…
next ›
last »